investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Training and Research in Colon Cancer Survival
Polly A. Newcomb
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Polly A. Newcomb
Fred Hutchinson Cancer Research Center
Seattle, United States
Related projects
Ross L Prentice
Nutrition and Physical Activity Assessment Study (NPAAS)
Colorectum
Frank B Hu
Harvard Transdisciplinary Research in Energetics and Cancer Center
Colorectum
Xi Chen
Integrative prediction models for metastasis risk in colon cancer
Colorectum
Pathology
Meir Stampfer
Dietary and Hormonal Determinants of Cancer in Women
Colorectum
Leonard H. Augenlicht
Age and Diet: Major interacting factors that drive sporadic intestinal cancer
Colorectum
Ulrike Peters
Detection of Colorectal Cancer Susceptibility Loci Using Genome-Wide Sequencing
Colorectum
Charles S Fuchs
Impact of Celecoxib and Inflammation on Survival in Stage III Colon Cancer
Colorectum
Graham Casey
Functional Analysis of Genome Wide Associations in Colorectal Cancer
Colorectum
Christopher Garrett
The Survival Advantage Associated with Metformin Usage in Patients with Colorectal Cancer and Type II Diabetes
Colorectum